HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 74 | 78 | 94.9% | |
| HF004 | 2020 | 67 | 75 | 89.3% | |
| HF006 | 2021 | 74 | 82 | 90.2% | |
| HF006 | 2022 | 125 | 133 | 94.0% | |
| HF006 | 2023 | 138 | 141 | 97.9% |
